Commercial Real Estate Fund, Biotech Making Handheld Device That Rapidly Diagnoses Infections, Share Price Changes, Six Investment Opportunities!
Reg A+ offerings — Anyone can invest
CalTier Reality — Multi-Family and Commercial Real Estate Investment Fund
A diversified real estate portfolio for investors.
Multi-Family properties produce steady cash flows while maintaining lower volatility when compared to other real estate types. CalTier is based in San Diego, California. Max raise size $50 mill. Minimum investment $500.
GolfSuites 1 Inc. — Share price will change at midnight Dec 15th. GolfSuites is focused on building hybrid-golf centers for year-round play, entertainment and game improvement.
GolfSuites 1 pays a dividend at the annual rate of 8%, paid monthly. They are changing the share price soon. To lock in the current $5.10 share price complete your investment by midnight Pacific on Dec 15th. Minimum investment $500.
InSitu Biologics — Closing soon. Emerging Biotech company focusing on development of AnestaGel™, a long-lasting and long-acting non-opiate, non-addictive painkiller.
The InSitu Biologics offering is closing soon. Minimum investment $2,460.
Investment opportunities for Accredited Investors only
Quara is a Biotech company developing QuaraSense™, the first handheld sensor to detect bacterial infections in minutes.
The Quara Convertible Note earns 10% interest per year. If and when the SEC qualifies their Regulation A+ offering, the Convertible Notes will be converted into Reg A+ shares at a 60% discount — this discount will reduce on December 30th. Minimum investment $10,000.
ERC Homebuilders (Parent of ERC 1 Inc, which plans its own Reg A+). ERC will develop “build-to-rent” homes to capitalize on market demand driven by the cultural wave of millennials who seek single-family living, without the costs of buying their home.
KGEM Golf (Parent of Golf Suites 1 Inc, which is conducting its own Reg A+). Investors in KGEM Golf to receive an 8% annual dividend, paid monthly after investment, with the potential for appreciation in preferred share price. Minimum investment $10,000.
This article was previously published on manhattanstreetcapital.com.
See Conflict of interest details for Manhattan Street Capital here.
Rod Turner is the founder and CEO of Manhattan Street Capital, the #1 Growth Capital marketplace for mature startups and mid-sized companies to raise capital using Regulation A+. Turner has played a key role in building successful companies including Symantec/Norton (SYMC), Ashton Tate, MicroPort, Knowledge Adventure and more. He is an experienced investor who has built a Venture Capital business (Irvine Ventures) and has made angel and mezzanine investments in companies such as Bloom, Amyris (AMRS), Ask Jeeves and eASIC.
Manhattan Street Capital, 5694 Mission Center Rd, Suite 602–468, San Diego, CA 92108.
Manhattan Street Capital helps raise growth capital for Real Estate projects, Mid-Stage companies, and Mature Startups through Debt and Equity offerings using Regulation A+. Our website platform brings together companies seeking growth equity with prospective investors.